摘要
目的探讨中、重度内异症患者使用促性腺激素释放激素激动剂（GnRH-a）后联合腹腔镜保守性手术治疗的临床疗效及安全性。方法回顾性分析2007年1月至2010年1月在武汉大学人民医院就诊的68例中、重度内异症患者的临床资料。GnRH-a组25例，术前月经来潮第2天皮下注射GnRH-a（亮丙瑞林）3．75mg，每4周1次，共3个月；口服避孕药组23例，术前最后1次月经来潮第2天口服避孕药去氧孕烯-炔雌醇片1片，连续21d为1个疗程，共3个疗程；单纯手术组20例，手术前未用任何药物。3组患者均行腹腔镜手术，术后所有患者随访12个月，比较3组患者的手术时间、术中出血量、术后恢复情况、疼痛症状视觉模拟评分（VAS）、复发率等指标。结果GnRH-a组、口服避孕药组、单纯手术组手术时间分别为（68±18）、（80±21）、（90±24）min；术中出血量分别为（118±15）、（161±18）、（193±13）ml；以上两项指标GnRH-a组均低于另外两组，分别比较，差异均有统计学意义（P〈0．05）。GnRH-a组患者术后下床活动时间及肛门排气时间均早于口服避孕药组和单纯手术组，分别比较，差异均有统计学意义（P〈0．05）。治疗后随访至术后12个月，GnRH-a组、口服避孕药组以及单纯手术组VAS分别由术前3．8分（1．9-6．8分）、2．7分（1．3-5．5分）、1．9分（1．0-4．9分）下降至1．9分（1．1-2．8分）、1．8分（1．2-3．2分）、1．6分（1．0-3．6分），GnRH-a组下降最明显，与其他两组分别比较，差异均有统计学意义（P〈0．05）。GnRH-a组、口服避孕药组以及单纯手术组患者随访期间复发率分别为12％（3／25）、22％（5／23）、25％（5／25），GnRH-a组与其他两组分别比较，差异均有统计学意义（P〈0．05）。结论GnRH-a联合腹腔镜手术治疗内异症手术时间短、术中失血少、术后恢复快、痛经改善效果好、复发率低，短期疗效安全有效。
Objective To study the efficacy and safety of Gonadotropin-releasing hormone agonists （GnRH-a） combined with laparoscope conservative surgery in treatment of moderate or severe endometriosis. Methods From Jan. 2007 to Jan. 2010, 68 patients with moderate or severe undergoing treatment in Renmin Hospital of Wuhan University were enrolled in this retrospective study. Three groups were classified, which were 25 patients in GnRH-a group, subcutaneous injection Leuprorelin on the second day of menstruation, every 4 weeks for 3 months. Twenty-three patients in Marvelon group, orally one marvelon tablet on the second day of menstruation, continuous 21 days for one period of treatment for 3 courses. Twenty patients in surgery group, without any medicine used preoperatively. All patients were followed by 12 months and compare their surgery time, blood loss, recovery, visual analog scale （VAS）, and recurrence and so on. Results The operating time were （68 ± 18 ） min in GnRH-a group, （80 ± 21） min in Marvelon group and （90±24） min in surgery group. The amount of bleeding were （118±15 ） ml in GnRh-a group, （161±18 ） ml in Marvelon group and （193±13 ） ml in surgery group. There was significant lower in the operating time and amount of bleeding in GnRH-a group than those in other two groups （ P 〈 0. 05 ）. The activity time and the anus exhaust time were shorter in patients in GnRh-a group thanthose in the other two groups significantly（ P 〈 0. 05）. When followed up in 12 months after treatment, visual analogue scale had dropped from 3.8 （ 1.9 - 6. 8） to 1.9 （ 1.1 - 2. 8） in GnRh-a group, from 2. 7 （ 1.3 - 5.5） to 1.8 （1.2 -3.2） in Marvelon group and from 1.9（1.0 -4.9） to 1.6（1.0 -3.6 ） in surgery group. It was showed the most remarkable decreased VAS in GnRHa group when compared with the other two groups（P 〈 0. 05）. The recurrence rates were 12% （3/25） in GnRH-a group, 22% （5/23） in Marvelon group and 25% （5/25） in surgery group. It was found that the most significant lower recurrence was in GnRH-a group when compared with the other two groups （P 〈 0. 05）. Conclusions It was safe and efficacy that GnRH-a combined with laparoscopic conservative surgery were used in treatment of endometriosis. It could bring shorter operation time, less intraoperative blood loss, quick postoperative recover, the lower recurrence rate.
出处
《中华妇产科杂志》
CAS
CSCD
北大核心
2013年第3期180-182,共3页
Chinese Journal of Obstetrics and Gynecology
